- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03287037
The Effects of tDCS on Depressive Symptoms,Neurocognitive Function and HRV in Unipolar Depression and Bipolar Depression
To Investigate the Effect of Transcranial Direct Current Stimulation (tDCS) on Depressive Symptoms, Neurocognitive Function and Heart Rate Variability in Unipolar Depression and Bipolar Depression
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Background
Transcranial direct current stimulation encompasses the induction of a relatively weak constant current flow through the cerebral cortex via scalp electrodes . Dependent on stimulation polarity, this results in a modulation of cortical excitability and spontaneous neural activity. The technique was established in the 1950s and 1960s primarily in animals. In these early studies it was shown that subthreshold DC stimulation increases spontaneous neuronal activity if the anode is placed above or within the cortex, while exposure to cathodal polarity results in reduced activity. This is caused by a subthreshold membrane depolarization by anodal and a hyperpolarization by cathodal stimulation. It was demonstrated in humans that the after-effects of tDCS depend on modifications of NMDA receptor-efficacy. The after-effects of tDCS are blocked by the NMDA receptor antagonist dextromethorphan, and prolonged by the partial NMDA receptor-agonist D-cycloserine. This tDCS polarity-dependent alteration of NMDA receptor function seems to be initiated by the respective membrane potential shift and probably by the accompanying cortical activity modification,because it is prevented by the sodium channel blocker carbamazepine. Intraneuronal calcium concentration also contributes, because calcium channel antagonists eliminate the excitability-enhancing after-effects of anodal tDCS. Recently, tDCS has been reported to be a novel, non-invasive and safe therapeutic tool to treat neuropsychiatric disorders including depression. This therapeutic tool has been reported to show promising effect in treating unipolar and bipolar depression. However, the sample sizes have been small. Further work is needed to see if these early promising studies replicate. Much evidence has indicated that patients with depression show hypoactivity over left dorsolateral prefrontal cortex (DLPFC) and hyperactivity over right DLPFC. We therefore hypothesize that tDCS over DLPFC with anode placed at left DLPFC and cathode placed at right DLPFC would reduce depressive symptoms in patients with unipolar depression and bipolar depression.
The study aimed to investigate whether tDCS over DLPFC could modify depressive symptoms, neurocognitive function and heart rate variability of unipolar and bipolar depression.
Study design: open-label study.
Participants: 60 patients with unipolar depression and 60 with bipolar depression.
Others: see Arms and Interventions, Eligibility Criteria or Outcome Measures.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Taipei, Taiwan, 114
- TRI-Service General Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
Patients who met DSM-IV-TR criteria for major depressive disorder and bipolar depression and had moderate to severe depression severity (HAM-D score more than 17) were included in the study.
Exclusion Criteria:
- pregnancy or breastfeeding.
- having epilepsy, severe physical illness, any current psychiatric comorbidity or history of substance dependence.
- having contraindications for transcranial electrical/magnetic stimulation.
- having intracranial metal foreign bodies.
- having a history of intracranial neoplasms or surgery, or a history of severe head injuries or cerebrovascular diseases.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: tDCS over DLPFC
Direct current (DC) generated by a DC stimulator (Eldith DC stimulator: www.
neuroconn.de/dc-stimulator_plus_en/)
was bilaterally delivered through a pair of saline-soaked surface sponge electrodes (35 cm2).
The anodal electrode was placed over the left dorsolateral prefrontal cortex (F3, International EEG System 10-20) and cathode electrode over F4.
Stimulation was applied at an intensity of 2 mA for 20 min, twice-daily on 5 consecutive weekdays.
The twice daily sessions were separated by at least 3 hours.
|
We applied tDCS over dorsolateral prefrontal cortex (DLPFC) for these depressed patients.
Direct current (DC) generated by a DC stimulator (Eldith DC stimulator: www.
neuroconn.de/dc-stimulator_plus_en/)
was bilaterally delivered through a pair of saline-soaked surface sponge electrodes (35 cm2).
The anodal electrode was placed over the left dorsolateral prefrontal cortex (F3, International EEG System 10-20) and cathode electrode over F4.
Stimulation was applied at an intensity of 2 mA for 20 min, twice-daily on 5 consecutive weekdays.
The twice daily sessions were separated by at least 3 hours.
All patients were maintained on their treatment throughout the study period.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Changes from baseline score of Hamilton Depression Rating Scale (HAM-D) at the timepoint immediately after tDCS, at one week and one month after tDCS
Tijdsspanne: One month
|
Depression severity
|
One month
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Changes from baseline score of Young Mania Rating Scale (YMRS) at the timepoint immediately after tDCS, at one week and one month after tDCS
Tijdsspanne: One month
|
Hypomania/mania severity
|
One month
|
Changes from baseline score of Hamilton Anxiety Rating Scale (HAM-A) at the timepoint immediately after tDCS, at one week and one month after tDCS
Tijdsspanne: One month
|
Anxiety severity.
|
One month
|
Changes from basline heart rate variability (HRV) at the timepoint immediately after tDCS, at one week and one month after tDCS
Tijdsspanne: One month
|
Index of autonomic functioning.
|
One month
|
Changes from baseline results of continuous performance test (CPT) at the timepoint immediately after tDCS, at one week and one month after tDCS
Tijdsspanne: One month
|
Performance of prefrontal-mediated task.
|
One month
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2-103-03-002-1
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Depressieve stoornis, majoor
-
University of HoustonOnbekend
-
New York City Health and Hospitals CorporationBeëindigdGlaucoom | Ziekte van het netvlies | Visuele Pathway DisorderVerenigde Staten
-
Air Force Military Medical University, ChinaVoltooidEffect van cap-geassisteerde esophagogastroduodenoscopie op observatie van majeure duodenale papillaObservatie van Major Duodenal Papilla (MDP)China
-
Neuro-Eye Diagnostic Systems, LLCNeuro-ophthalmology of Texas PLLCAanmelden op uitnodigingMacula ziekte | Visuele Pathway Disorder | Ziekte van de oogzenuwVerenigde Staten
-
CorrectSequence Therapeutics Co., LtdWervingBèta-thalassemie MajorChina
-
First Affiliated Hospital of Guangxi Medical UniversityOnbekend
-
bluebird bioVoltooidSikkelcelziekte | Bèta-thalassemie MajorFrankrijk
-
Memorial Sloan Kettering Cancer CenterActief, niet wervendBevestigde diagnose van ß-thalassemie MajorVerenigde Staten
-
BGI-researchShenzhen Children's HospitalNog niet aan het werven
-
Aghia Sophia Children's Hospital of AthensOnbekendAsplenie | β-thalassemie MajorGriekenland
Klinische onderzoeken op tDCS over DLPFC
-
Federal University of ParaíbaVoltooidAutistische stoornissen SpectrumBrazilië
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)WervingErnstige depressieve stoornisVerenigde Staten
-
Samsung Medical CenterVoltooidCognitieve stoornissen na een beroerteKorea, republiek van
-
Samsung Medical CenterVoltooidMilde cognitieve stoornisKorea, republiek van
-
Hospital de Clinicas de Porto AlegreVoltooidPijn | Werkgeheugen | Transcraniële gelijkstroomstimulatieBrazilië
-
Johns Hopkins UniversityYbrain Inc.Aanmelden op uitnodigingDementie | Milde cognitieve stoornis | Primaire progressieve afasieVerenigde Staten
-
Charles Darwin UniversityWervingAan het leren; Gebrek aan (specifiek)Australië
-
Centre Hospitalier Universitaire de BesanconFondation FondaMentalWervingSuïcidale gedachten | Impulsief gedrag | Unipolaire depressieFrankrijk
-
Stanford UniversityVoltooidBehandelingsresistente depressieVerenigde Staten
-
Changping LaboratoryXianyue Hospital, Xiamen; Hebei Mental Health Center, Baoding; HuiLongGuan Hospital... en andere medewerkersWervingBehandelingsresistente depressieChina